Anders Berkenstam
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Retinoids in leukemia and cellular processes 3
- Genetics 11
- Estrogen and related hormone effects 11
- Co-authors
- Göran Bertilsson (5 shared papers)Kristian Svensson (3 shared papers)Lena Jendeberg (4 shared papers)Patrik Blomquist (2 shared papers)Rolf Ohlsson (1 shared paper)Hans Postlind (1 shared paper)Hans Glaumann (10 shared papers)Yihai Cao (1 shared paper)
- Journals
- Journal of Biological Chemistry (3 papers)Experimental Cell Research (2 papers)Experimental and Molecular Pathology (2 papers)Molecular Endocrinology (2 papers)Nature (2 papers)
- Partner nations
- SwedenUnited StatesGermany
In The Last Decade
Anders Berkenstam
33 papers receiving 2.9k citations
Anders Berkenstam's Hit Papers
Peers
Comparison fields: 5 of 100
- Pharmacology 641
- Cancer Research 524
- Genetics 1.0k
- Endocrinology, Diabetes and Metabolism 531
- Oncology 603
Countries citing papers authored by Anders Berkenstam
This map shows the geographic impact of Anders Berkenstam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Berkenstam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Berkenstam more than expected).
Fields of papers citing papers by Anders Berkenstam
This network shows the impact of papers produced by Anders Berkenstam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Berkenstam. The network helps show where Anders Berkenstam may publish in the future.
Co-authors
The 25 scholars most cited alongside Anders Berkenstam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Identification of a human nuclear receptor defines a new signaling pathway for CYP 3 A induction Hit paper breakdown → | 1998 | 753 |
| 2 | Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression Hit paper breakdown → | 2001 | 562 |
| 3 | 1998 | 227 | |
| 4 | 2007 | 164 | |
| 5 | 1991 | 125 | |
| 6 | 1996 | 121 | |
| 7 | 1992 | 114 | |
| 8 | 1989 | 108 | |
| 9 | 1995 | 97 | |
| 10 | 1985 | 95 | |
| 11 | 1988 | 69 | |
| 12 | 2001 | 66 | |
| 13 | 1997 | 63 | |
| 14 | 1993 | 52 | |
| 15 | 1993 | 48 | |
| 16 | 2005 | 43 | |
| 17 | 2016 | 36 | |
| 18 | 2002 | 36 | |
| 19 | 1990 | 33 | |
| 20 | 1987 | 31 |
About Anders Berkenstam
Anders Berkenstam is a scholar working on Molecular Biology, Genetics, Oncology, Endocrinology, Diabetes and Metabolism and Epidemiology, having authored 34 papers that have together received 3.0k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (11 papers), Hormonal Regulation and Hypertension (6 papers), Autophagy in Disease and Therapy (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Retinoids in leukemia and cellular processes (3 papers), Computational Drug Discovery Methods (3 papers) and Nuclear Receptors and Signaling (3 papers). The work is most often cited by research in Pharmacology (641 citations), Cancer Research (524 citations), Genetics (1.0k citations), Endocrinology, Diabetes and Metabolism (531 citations) and Oncology (603 citations). Anders Berkenstam has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Göran Bertilsson, Kristian Svensson, Lena Jendeberg, Patrik Blomquist, Rolf Ohlsson, Hans Postlind, Hans Glaumann, Yihai Cao, Hirotoshi Tanaka and Renhai Cao. Their work appears in journals such as Journal of Biological Chemistry, Experimental Cell Research, Experimental and Molecular Pathology, Molecular Endocrinology and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.